Researchers design a new vaccine that could increase the number of antibodies that could attach to nicotine molecules

Trioxacarcin molecules bind to the DNA of targeted cells and prevent them from replicating

Brookhaven-designed accelerator has the potential to increase cure rates in cancer treatment while minimizing radiation dose and damage to healthy tissue.

“The future of cancer research is here.”

"The bottom line is that so far there are only a few successful nanoparticle formulations approved and clinically used, so we need to start thinking out of the box."

Attached to strands of DNA, they change shape, size, and chemistry to access diseased tissue, like a key fitting into a lock

Scientists at the University of East Anglia are getting closer to solving the problem of antibiotic resistance.

Development of nanomedicines will target specific cells without compromising immunity

Sample preparation is required to remove matrix interferences from urine samples prior to LC-MS/MS analysis.

A research team that included scientists from The Scripps Research Institute (TSRI) has identified a new group of powerful antibodies to fight Ebola virus.

Fighting chemoresistant cancer remains a huge challenge that scientists are tackling from as many angles as they can

A tunable protein piston that breaks membranes to release encapsulated cargo